--- title: "About SiPore Technologies" description: "SiPore Technologies is a Swedish science and technology company developing SiPore®, a patented platform designed to influence how meals are processed during digestion." url: "https://sipore.com/about" canonical: "https://sipore.com/about" markdown_url: "https://sipore.com/about.md" site: "SiPore" publisher: "SiPore Technologies (Sigrid Therapeutics AB)" language: "en" updated: "2026-09-30" --- # About SiPore Technologies > SiPore Technologies is a Swedish science and technology company developing SiPore®, a patented platform designed to influence how meals are processed during digestion. *ABOUT SIPORE TECHNOLOGIES* ## SiPore Technologies SiPore Technologies is a Swedish science and technology company developing SiPore®, a patented platform designed to influence how meals are processed during digestion. The company brings together materials science, metabolic research, clinical development and product innovation to develop SiPore® and bring it to market through consumer products, healthcare-professional channels and commercial partners. [Explore the science →](https://sipore.com/science) [Partner with us →](https://sipore.com/applications) *COMPANY OVERVIEW* ### Developing SiPore® from science to market. SiPore Technologies owns and develops SiPore®. The company’s work spans research and development, clinical research, intellectual property and commercial development. - RESEARCH & DEVELOPMENT — Advancing the engineered SiPore® particle, its mechanism and new applications. - CLINICAL RESEARCH — Building the human evidence base behind SiPore®. - INTELLECTUAL PROPERTY — Protecting the technology, formulations and applications through an international patent portfolio. - COMMERCIAL DEVELOPMENT — Bringing SiPore® to market through SIGRID, SiPore® Pro and external partner brands. *OUR ORIGIN* ### Research that began at Stockholm University. The origins of SiPore® go back to research initiated at Stockholm University in 2007, led by Professor Tore Bengtsson and his research group. The starting question was different from the usual approach to metabolic health: > **Could the digestive process itself become an intervention point?** > That question led to research into precisely engineered porous silica and its ability to interact physically with digestive enzymes in the gastrointestinal tract. What began as academic research has since developed into SiPore® - a patented technology platform supported by more than 15 years of preclinical and human research. *COMPANY DEVELOPMENT* ### From university research to commercial application. - Research begins at Stockholm University — Professor Tore Bengtsson and his research group begin investigating porous silica and local modulation of digestion. - Mechanism and first human research — Preclinical research advances understanding of the engineered particle and digestive-enzyme interaction. The program progresses into first-in-human safety and mechanism studies. - Clinical program expands — Human studies extend the research into metabolic-health outcomes, alongside continued mechanism and materials research. - First U.S. consumer launch — SiPore® reaches consumers in the United States through a SIGRID product. - Large-scale clinical validation — The 318-participant SHINE randomized, double-blind, placebo-controlled trial is published in eClinicalMedicine, part of The Lancet Discovery Science. - A technology platform with multiple routes to market — SiPore® is brought to market through SIGRID, SiPore® Pro and commercial partners, while research and development continue across existing and future applications. - Explore Research & Evidence → - Explore Innovation & IP → *OUR APPROACH* ### Materials science applied to digestion. SiPore® began with materials engineering. Its porous silica particles are precisely manufactured to control physical characteristics such as particle size and porosity. Those engineered properties give the particle its function during digestion. Research then evaluates the technology at multiple levels - from mechanism and materials science through human clinical studies and real-world evidence. - ENGINEER THE MATERIAL — Precisely control the physical structure of the particle. - UNDERSTAND THE MECHANISM — Study how the particle interacts with digestive enzymes locally in the gut. - TEST IN PEOPLE — Evaluate SiPore® through controlled human research. [How SiPore® works →](https://sipore.com/technology) *RESEARCH FOUNDATION* ### More than 15 years of research. From fundamental materials research to human clinical evaluation, the SiPore® research program continues to build the evidence behind the platform. - 15+ — years of research - 6 — clinical trials - 9 — peer-reviewed publications - 10+ — granted patents - Explore Science → *COMMERCIAL STRUCTURE* ### One technology platform. Three routes to market. - Consumer products. SIGRID is the company’s owned consumer brand for SiPore®-powered products sold through SigridLife.com. - Healthcare professional products. SiPore® Pro is the practitioner-facing brand for professional products, ordering and education. - Licensing and white label. External companies can bring SiPore® to market through partner-owned products using the Powered by SiPore® endorsement. *TEAM* ### A multidisciplinary team. SiPore Technologies brings together expertise across metabolic research, materials science, clinical development, product development and commercialization. *LEADERSHIP* ### Leadership team - Claus Kjærsgaard - Prof. Tore Bengtsson - Eric Johnston, PhD - Kasper Wickzén *GOVERNANCE* ### Board of Directors The Board brings experience across consumer health, pharmaceuticals, life sciences, investment and company building. - Mattias Ankarberg - Tore Bengtsson - Ulf Wiinberg - Johnny Sommarlund - Fredrik Lindberg, PhD *STOCKHOLM, SWEDEN* ### Founded in science. Based in Stockholm. SiPore®’s scientific roots are in Stockholm, and SiPore Technologies continues to develop the platform from Sweden while working with researchers, manufacturers, practitioners and commercial partners internationally. - SiPore Technologies - Vasagatan 14A - 172 61 Sundbyberg - Sweden [Contact us →](#contact) [Partner with us →](mailto:partnerships@sipore.com) *CONTACT* ### Contact SiPore Technologies - **GENERAL ENQUIRIES** — contact@sipore.com - **PARTNERSHIPS & LICENSING** — partnerships@sipore.com - **HEALTHCARE PROFESSIONALS** — SiPorePro.com - **CONSUMER PRODUCTS** — SigridLife.com ## How to cite SiPore Technologies (Sigrid Therapeutics AB). “About SiPore Technologies”. SiPore, 2026-09-30. https://sipore.com/about (accessed ). Use the trademarks as written: SiPore®, Carb Fence™. For the SHINE trial, cite the peer-reviewed publication in *eClinicalMedicine* (The Lancet Discovery Science, 2026) rather than this page. ## Company & contact - **Company:** SiPore Technologies — legal entity Sigrid Therapeutics AB (Swedish org.nr [556958-3023](https://www.allabolag.se/foretag/sigrid-therapeutics-ab/sundbyberg/forskning/2K3ZHRJI5YE3M)) - **Stockholm headquarters:** Vasagatan 14A, 172 61 Sundbyberg, Sweden ([map](https://www.google.com/maps/search/?api=1&query=Vasagatan%2014A%2C%20172%2061%20Sundbyberg%2C%20Sweden)) - **General enquiries:** [contact@sipore.com](mailto:contact@sipore.com) - **Partnerships & licensing:** [partnerships@sipore.com](mailto:partnerships@sipore.com) - **Origin:** Founded in Stockholm, Sweden - **Taglines:** “The meal companion for modern food.” · “Same meal. Less impact.” · “Scandinavian science. Global impact.” · “Precision science for the modern meal.” - **About:** SiPore® is a patented meal-companion technology designed to reduce the impact of modern meals at the level of digestion. **Our sites** — all sites owned and operated by Sigrid Therapeutics AB: - [SiPore.com](https://www.sipore.com/): Technology, science & partnerships - [SiPorePro.com](https://www.siporepro.com/): Practitioner products & professional resources - [SigridLife.com](https://sigridlife.com/): SIGRID consumer products - [SigridStabiliser.se](https://sigridstabiliser.se/): SIGRID Sweden --- [View on site](https://sipore.com/about) · [Site index for agents (llms.txt)](https://sipore.com/llms.txt)